What is InSitu Technologies?
Headquartered in Saint Paul, Minnesota, InSitu Technologies operates as a specialized developer and manufacturer of advanced cardiovascular solutions. With a legacy spanning over 25 years, the company has established a robust reputation for delivering minimally invasive devices, most notably the Celosia and Silene covered stents. Their operational model centers on deep collaboration with global medical professionals, ensuring that their engineering efforts remain aligned with the evolving needs of coronary and peripheral stenting procedures. Currently serving healthcare providers across more than 40 countries, the firm maintains a critical role in the medical technology ecosystem by bridging the gap between complex engineering and improved patient outcomes.
How much funding has InSitu Technologies raised?
InSitu Technologies has raised a total of $41K across 1 funding round:
Debt
$41K
Debt (2021): $41K with participation from PPP
Key Investors in InSitu Technologies
PPP
Public-Private Partnership
What's next for InSitu Technologies?
With the successful acquisition of $41K, InSitu Technologies is entering a pivotal phase of growth. The company is expected to utilize this investment to deepen its research and development capabilities, potentially expanding its pipeline of innovative, minimally invasive devices. As the firm transitions through its current Series B/C stage, the focus will likely shift toward optimizing manufacturing efficiencies and scaling distribution networks to penetrate emerging markets. By maintaining its collaborative approach with physicians, InSitu Technologies is well-positioned to navigate the regulatory and clinical complexities of the global cardiovascular market, ultimately driving long-term value for stakeholders and improving the standard of care for patients worldwide.
See full InSitu Technologies company page
